Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
143
currently held
Exits tracked
27
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Capital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin162 companies matching · Page 2 of 4
Ascend Gene & Cell Therapies
Abingworth Bioventures 8
Sector
Biotech
InvestorAbingworth
Entry
2023
Hold
3yr
AstronauTx
Dementia Discovery Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2019
Hold
7yr
Awen Oncology
Development Bank of Wales (Balance Sheet)
Sector
Biotech
InvestorDevelopment Bank of Wales
Entry
2024
Hold
2yr
Axovia Therapeutics
ALSA Ventures European Biotechnology Fund
Sector
Biotech
InvestorALSA Ventures
Entry
2023
Hold
3yr
Barinthus Biotherapeutics
Future Planet Fund I
Sector
Biotech
InvestorFuture Planet Capital
Entry
2020
Hold
6yr
Baseimmune
IQ Capital Fund III
Sector
Biotech
InvestorIQ Capital Partners
Entry
2021
Hold
5yr
Beacon Therapeutics
Oxford Science Enterprises Balance Sheet
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2023
Hold
3yr
BioAscent
Maven Income and Growth VCT 4
Sector
Biotech
InvestorMaven Capital Partners
Entry
2018
Hold
8yr
Biocolor Ltd
QUBIS Ltd
Sector
Biotech
InvestorQubis
Entry
1993
Hold
33yr
BioOrbit
Breega Seed fund
Sector
Biotech
InvestorBreega
Entry
2026
Hold
0yr
Bitrobius Genetics
UK Innovation and Science Seed Fund
Sector
Biotech
InvestorFuture Planet Capital
Entry
2023
Hold
3yr
BiVictriX Therapeutics
Development Bank of Wales (Balance Sheet)
Sector
Biotech
InvestorDevelopment Bank of Wales
Entry
2016
Hold
10yr
Concinnity Genetics
Old College Capital LP
Sector
Biotech
InvestorOld College Capital
Entry
2024
Hold
2yr
ConstructiveBio
Amadeus V Technology Fund
Sector
Biotech
InvestorAmadeus Capital Partners
Entry
2022
Hold
4yr
CoSyne Therapeutics
Backed Fund II
Sector
Biotech
InvestorBACKED VC
Entry
2022
Hold
4yr
Crucible Therapeutics
Northern Gritstone Evergreen
Sector
Biotech
InvestorNorthern Gritstone
Entry
2023
Hold
3yr
Cumulus Oncology
Scottish National Investment Bank (Balance Sheet)
Sector
Biotech
InvestorScottish National Investment Bank
Entry
2024
Hold
2yr
CV6 Therapeutics
Co-Fund NI
Sector
Biotech
InvestorClarendon Fund Managers
Entry
2022
Hold
4yr
CV6 Therapeutics (NI) Ltd
QUBIS Ltd
Sector
Biotech
InvestorQubis
Entry
2019
Hold
7yr
Draig Therapeutics
SV7 Impact Medicine Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2025
Hold
1yr
Elasmogen
Scottish National Investment Bank (Balance Sheet)
Sector
Biotech
InvestorScottish National Investment Bank
Entry
2022
Hold
4yr
EnsiliTech
Elbow Beach Capital
Sector
Biotech
InvestorElbow Beach Investments
Entry
2023
Hold
3yr
EnteroBiotix
Scottish National Investment Bank (Balance Sheet)
Sector
Biotech
InvestorScottish National Investment Bank
Entry
2024
Hold
2yr
Epitopea
CIC Fund II
Sector
Biotech
InvestorCambridge Innovation Capital
Entry
2022
Hold
4yr
Epsilogen
ALSA Ventures European Biotechnology Fund
Sector
Biotech
InvestorALSA Ventures
Entry
2018
Hold
8yr
Etheros
Backed Fund III
Sector
Biotech
InvestorBACKED VC
Entry
2023
Hold
3yr
Evox Therapeutics
Oxford Science Enterprises Balance Sheet
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2016
Hold
10yr
Exonate
Angel CoFund
Sector
Biotech
InvestorACF Investors
Entry
2016
Hold
10yr
FabricNano
Backed Fund II
Sector
Biotech
InvestorBACKED VC
Entry
2019
Hold
7yr
FibroFind
Vespa Capital III
Sector
Biotech
InvestorVespa Capital
Entry
2025
Hold
1yr
GenoME Diagnostics
Co-Fund NI
Sector
Biotech
InvestorClarendon Fund Managers
Entry
2023
Hold
3yr
Glen Clova Scientific
DSW Ventures
Sector
Biotech
InvestorDSW Venture Capital
Entry
2024
Hold
2yr
Harness Therapeutics
Dementia Discovery Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2020
Hold
6yr
Ikarovec
LifeArc Ventures
Sector
Biotech
InvestorLifeArc
Entry
2020
Hold
6yr
Immutrin
CIC Fund II
Sector
Biotech
InvestorCambridge Innovation Capital
Entry
2025
Hold
1yr
Invizius
Old College Capital LP
Sector
Biotech
InvestorOld College Capital
Entry
2019
Hold
7yr
iosBio
Shackleton Ventures (Evergreen)
Sector
Biotech
InvestorShackleton Ventures
Entry
2020
Hold
6yr
LabGenius
Backed Fund I
Sector
Biotech
InvestorBACKED VC
Entry
2017
Hold
9yr
LambdaVision
Seraphim Space Ventures II
Sector
Biotech
InvestorSeraphim Space
Entry
2024
Hold
2yr
Locate Bio
Mercia Direct Investments
Sector
Biotech
InvestorMercia Asset Management
Entry
2021
Hold
5yr
LoQus23 Therapeutics
Dementia Discovery Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2019
Hold
7yr
Macomics
Old College Capital LP
Sector
Biotech
InvestorOld College Capital
Entry
2020
Hold
6yr
MatchBio
Oxford Science Enterprises Balance Sheet
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2024
Hold
2yr
Medinect Bioservices Ltd
QUBIS Ltd
Sector
Biotech
InvestorQubis
Entry
2022
Hold
4yr
Mereo BioPharma
Rosetta Capital V
Sector
Biotech
InvestorRosetta Capital
Entry
2021
Hold
5yr
Mesenbio
DSW Ventures
Sector
Biotech
InvestorDSW Venture Capital
Entry
2024
Hold
2yr
Mestag Therapeutics
SV7 Impact Medicine Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2021
Hold
5yr
Mosaic TX
CIC Fund II
Sector
Biotech
InvestorCambridge Innovation Capital
Entry
2023
Hold
3yr
Multiomic Health
MMC Ventures EIS Fund
Sector
Biotech
InvestorMMC Ventures
Entry
2023
Hold
3yr
Mytos
IQ Capital Fund IV
Sector
Biotech
InvestorIQ Capital Partners
Entry
2023
Hold
3yr